Objectives-The aim of this study was to noninvasively demonstrate the presence of early risk associated with subclinical inflammatory activity in patients with familial Mediterranean fever (FMF) who had stable disease, using ultrasound (US) radiofrequency data technology.
F
amilial Mediterranean fever (FMF) is an autosomal recessively transmitted autoinflammatory disease characterized by recurrent inflammation of the serosal and synovial membranes, and its course includes exacerbations presenting with symptoms such as fever, peritonitis, pleuritis, myalgia, and erysipelas-like skin lesions. 1 The gene causing FMF (MEFV) is located on the short arm of the 16th chromosome (16p13), and it encodes for the pyrin/marenostrin protein, consisting of 781 amino acids. Pyrin is primarily expressed in the neutrophils and monocytes. 2 In patients with FMF, the pyrin protein defect results in recurrent inflammatory events via an insufficient and prolonged response to inflammatory stimuli and increased leukocyte migration to serosal sites. 3 During an inflammatory episode, the levels of inflammatory serum markers such as the white blood cell count, erythrocyte sedimentation rate, C-reactive protein, serum amyloid A, and plasma fibrinogen increase. 2 Patients are exposed to cardiovascular risk due to the recurrent and prolonged inflammatory status. Persistent chronic inflammation results in endothelial dysfunction by increasing vascular permeability and nitric oxide synthesis. Endothelial dysfunction plays a crucial role in the development of atherosclerosis. 4 Subclinical atherosclerotic alterations show their effects on the arterial wall by increasing intima-media thickness and decreasing vascular elasticity. 5 Carotid artery intima-media thickness measurement represents a valid method of predicting early atherosclerosis onset and the potential cardiovascular events in the general population. 5 In the evaluation of the decline in the arterial elasticity, major parameters include vascular stiffness, distensibility, strain, and the pressure-strain elastic modulus. 5, 6 With the introduction of advancements in ultrasound (US) technology, automated and exact measurement of the carotid intima-media thickness can be performed, and US radiofrequency (RF) data technology enables the measurement of arterial elasticity. This method has many advantages, as it integrates the RF data technology and B-mode imaging (visual morphologic characteristics), allowing assessments of the walls of blood vessels and real-time feedback on measurement quality. 5 In this study, the CCA intima-media thickness and arterial stiffness of patients with FMF without any cardiovascular risk factors and those of a control group were noninvasively measured by the RF data technology, and the results were comparatively evaluated between the groups and with respect to clinical and laboratory findings within the patient group. We aimed to demonstrate the presence of early vascular disease risk due to subclinical inflammatory activity during exacerbation-free periods of the disease in patients with FMF.
Materials and Methods

Study Group and Clinical Assessment
This study was conducted between February 2017 and April 2017 and included 55 patients with FMF, who were followed by the rheumatology clinic and had no other inflammatory rheumatoid disease, and 55 healthy control participants. The diagnosis of FMF was made according to the Tel Hashomer criteria. 7 Those with coronary artery disease, peripheral artery disease, hypertension, hyperlipidemia, diabetes mellitus, or chronic renal failure and those using drugs affecting arterial stiffness (eg, antihypertensive, antidiabetic, and antilipidemic drugs) were excluded from the study. The study was approved by the Clinical Trials Ethics Committee before initiation (approval No. 16.01.17/34/24) and conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from each participant.
Ultrasound Assessment
The systolic blood pressure (BP) and diastolic blood pressure (BP) were measured by the oscillometric method in the US unit of the radiology clinic after approximately 10 minutes of resting (M-6; Omron Healthcare Company, Ltd, Kyoto, Japan). The pulse pressure was calculated by subtracting the diastolic BP from the systolic BP. Height (meters), weight (kilograms), and body mass index (kilograms per square meter) measurements for the patient and control groups were recorded in the US unit on the same day as the carotid intima-media thickness measurements.
Patients' identification information and their systolic and diastolic BP values were recorded in the US device, which functioned on a MyLab 60 platform (Esaote SpA, Genoa, Italy) with a high-resolution 12-MHz linear sequence transducer (LA523). The device was equipped with RF Quality Intima-Media Thickness Analysis and RF Quality Arterial Stiffness Analysis software, which worked with the RF method. The measurements were obtained at 45 8 head elevation in a lying position while the head was rotated to the left or to the right at 30 8 based on the location of the carotid system examined. Intima-media thickness measurements were obtained from B-mode examinations by using US RF monitoring technology (RF Quality Intima-Media Thickness Analysis) from the distant CCA wall at a 10-mm distal segment, where appropriate images were obtained from the longitudinal plane and no plaque was visualized. To run the software, first the Tools button on the device was tapped. The same button was tapped once more on the pop-up screen to activate the RF Quality Intima-Media Thickness Analysis software. After 6 cardiac cycles, the software calculated a real-time mean intima-media thickness value and its standard deviation. When the standard deviation value was 20 lm or lower, the color of the standard deviation value shown in the small box located next to the intima-media thickness measurement area turned green. The screen was paused at this stage, and the button on the front console was tapped to record the side of the CCA where the measurement was obtained ( Figure 1 ). The same steps were repeated on the other side of the CCA, and the appropriate CCA side was recorded. Afterward, Measurement was tapped to numerically show intima-media thickness values of both CCAs, as presented in Figure 2 .
After intima-media thickness measurements were completed, the Tools button was tapped again, and the RF Quality Arterial Stiffness Analysis software was selected. Using this software, arterial wall movements were monitored by RF signals at systolic and diastolic phases during 6 cardiac cycles in B mode examinations, in which the CCA was appropriately visualized on a vertical plane of 10-mm distal segments without any visible plaque, and real-time mean arterial distension, diameter, and standard deviation values were calculated. Where appropriate standard deviation values of 25 lm or lower were achieved, the color of the small box showing the value adjacent to the measurement area turned green. The screen was paused at this stage, and the button on the front console was tapped to record the side of the CCA where the measurement was obtained. The same steps were repeated on the other CCA; the appropriate CCA side was recorded; and then the Measurement button was used to see the individual numeric atherosclerosis values of both CCAs.
The RF quality arterial stiffness Analysis technology provides a list of stiffness parameters calculated by measuring the arterial distension waveform combined with the brachial artery BP. Parameters obtained with the RF quality arterial stiffness analysis technology have been defined in the RF Quality Arterial Stiffness Analysis software. These parameters are calculated using the following formulas. 8, 9 The parameters D and DD refer to the diastolic diameter and the change in diameter during systole, respectively. P s and P d are the systolic and diastolic BPs; DP is the pulse pressure; and r is the blood density. 1. The parameter DC refers to the absolute change in vessel diameter during systole for a given pressure change and is calculated by the following formula:
The parameter CC is the relative change in the vessel diameter during systole for a given pressure change and is calculated by the following formula: Figure 1 . Left CCA quality intima-media thickness analysis. The red line represents the RF signal following the anterior edge of the mediaadventitia interface, and the green line represents the RF signal following the anterior edge of the lumen-intima interface. 
The parameter a relates the cross-sectional area change to the driving pressure and is calculated as follows:
4. The parameter b indicates the degree of atherosclerosis, and it increases in the presence of atherosclerosis:
The parameter PWVb is the travel speed of the pulsed wave. PWV? will be higher if the artery is stiffer: Figures 3 and 4 show the quality arterial stiffness analysis of the right CCA and atherosclerosis values of both CCAs.
Statistical Analyses
Statistical analyses were performed with SPSS version 22.0 software for Windows version (IBM Corporation, Armonk, NY). Descriptive statistics were expressed as means 6 standard deviations (ranges), frequencies, and percentages. The Pearson v
2 test was used to analyze categorical variables. Visual (histograms and probability diagrams) and analytic (Kolmogorov-Smirnov Test) methods were used to check whether the variables were normally distributed. For normally distributed variables, the Student t test was used to check any statistically significant differences between two independent groups. The Mann-Whitney U test was used to analyze the abnormally distributed variables. The relationships between variables were analyzed by Spearman correlation coefficients. P < .05 was considered statistically significant. Table 1 shows the demographic and clinical characteristics of the patients with FMF and the control group. There was no statistically significant difference between the patients with FMF and controls in terms of the right and left CCA intima-media thickness, calculated as the mean value of the right and the left sides, distensibility coefficient, elasticity coefficient, a and b stiffness indices, and pulsed wave velocity (P > .05). Table 2 shows the distribution of the right and left CCA hemodynamic parameters between the patients with FMF and controls. In addition, no statistically significant difference was found in the laboratory parameters between the patients with FMF and controls (P > .05; Table 3 ).
Results
The mean colchicine dose 6 SD used by the patients with patients was 1.46 6 0.16 (range, 1-2) mg/d, whereas their mean symptom duration was 15.09 6 10.23 (range, 2-40) days, and the mean diagnosis and treatment duration was 7.61 6 6.93 (range, 1-33) days. The symptom duration and diagnosis and treatment duration of the patients with patients had a moderate negative correlation with distensibility and compliance coefficient measurements obtained with carotid Doppler US, whereas a moderate positive correlation and statistically significant relationship was detected for the a stiffness index, b stiffness index, and pulsed wave velocity (P < .05; Table 4 ). No statistically significant correlations were found between the C-reactive protein, erythrocyte sedimentation rate, fibrinogen, white blood cell count, and neutrophil-tolymphocyte ratio values for the patients with FMF and their intima-media thickness and pulsed wave velocity values recorded with Doppler US (P > .05).
Discussion
In this study, we did not find significant differences in the CCA intima-media thickness and stiffness measurements between the patients with FMF and healthy control participants. To our knowledge, this work is the first study reported in the literature to investigate CCA intima-media thickness and stiffness in patients with FMF noninvasively by using RF data technology. Arterial stiffness in patients with FMF is associated with the degree of inflammation, rather than genetic mutations or the types of exacerbations during symptomatic Arterial stiffness is an early sign of atherosclerosis, and it is altered in the presence of chronic inflammatory diseases such as rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis. 10, 11 Familial Mediterranean fever is characterized by subclinical inflammation, which can occur outside the exacerbation periods. Some studies in the literature previously reported elevated CCA intima-media thickness and pulsed wave velocity values in patients with FMF. 12, 13 The pulsed wave velocity was suggested to be used as an indicator of arterial stiffness, and pulsed wave velocity measurement was predicted to be a precursor. 13 In this study, we did not find any significant difference between pulsed wave velocity values in the patients with FMF and controls.
Akdogan et al 14 previously reported that endothelialdependent vasodilatation was impaired and the CCA intima-media thickness was elevated in patients with FMF outside the exacerbation periods. They concluded that endothelial function is impaired and the atherosclerosis risk is elevated in patients with FMF. In line with our findings, another study reported comparable CCA intimamedia thickness and brachial artery flow-mediated dilatation values between patients with FMF and controls, and this finding was attributed to the regular colchicine therapy received by all patients included in the study.
14 All patients included in this study were also receiving regular colchicine therapy.
Evaluating the central role of the endothelium allows early detection of cardiovascular disease, estimation of cardiovascular risk, and assessment of the treatment response. 15 Currently, researchers have focused on methods that noninvasively estimate endothelial dysfunction and atherosclerosis: in other words, arterial stiffness measurements. Arterial stiffness measurement is recommended by current hypertension guidelines as an additional test for evaluation of hypertensive patients. 16 Moreover, arterial stiffness and endothelial dysfunction markers were shown to be elevated by increased blood glucose levels in prediabetic patients and those with newly diagnosed diabetes. 17 Carotid artery intima-media thickening and increased arterial stiffness are considered precursors of cardiovascular disease-associated morbidity and mortality. 17 Familial Mediterranean fever is an autoinflammatory disease, and the nature of inflammation is distinct from that of other rheumatic diseases such as rheumatoid arthritis and systemic lupus erythematosus. 18 The absence of responses to nonsteroidal antiinflammatory drugs and corticosteroids during acute exacerbations of FMF and dramatic responses obtained by colchicine in prevention of an acute exacerbation and inhibition of the development of amyloidosis suggest the argument that the mechanism of inflammation differs between FMF and the other rheumatic diseases. 18, 19 Serious inflammation occurs during an FMF exacerbation and usually alleviates within 3 to 4 days; however, subclinical inflammation continues during exacerbationfree periods of FMF, even when the patients are receiving regular colchicine therapy. 20 Nevertheless, this lowseverity inflammatory response is not strong enough to accelerate atherosclerosis. Since colchicine is an alkaloid with anti-inflammatory characteristics, its regular use can be another contributor. 18 Therefore, the antiinflammatory activity of colchicine plays an important role in protection of endothelial function. 18 This study had a few limitations. It study was a single-center study, and the study sample was small. The study variables could have been more explicitly shown in a larger patient population including treatment-na€ ıve patients with FMF and patients in acute exacerbation periods of the disease.
In conclusion, subclinical inflammation that persists in patients with FMF outside exacerbation periods presents a risk for cardiovascular disease. Regular colchicine therapy reduces this risk, but patients still need to be closely monitored. Common carotid artery intimamedia thickness and arterial stiffness measurements can aid in early prediction of cardiovascular disease development in patients with FMF. Radiofrequency data technology provides a noninvasive method for accurately and quantitatively showing the CCA intima-media thickness elevation and the decrease in vascular elasticity in patients with FMF.
